Password required.
The strategic thesis. Most peptide brands fight for share at A4M, AMMG, AMWC. That market is crowded and expensive. The alpha is in massive trade shows where no peptide brand currently exhibits. Three patterns emerged from the scan:
1. Dental is the largest unconquered clinician audience. GNYDM (50k attendees), Chicago Midwinter (30k), CDA Presents (17k), AAO (10k+), Hinman (10k+). Zero peptide exhibitors at any of them in 2025 directories. BPC-157 and GHK-Cu have direct mechanism-of-action stories for periodontal regeneration, post-extraction healing, bone graft integration. AAOMS (oral surgeons) and AAP (periodontists) are the specialty meetings with the cleanest Rx scope.
2. Podiatry and hand surgery are second-tier goldmines. APMA The National for diabetic foot wound healing. ASSH for tendon and nerve regen. MD/DPM audiences with full Rx scope and cash-pay overlap.
3. The prescriber audience nobody hunts is NP/PA. AANP National (Vegas, Jun 23-27) draws thousands of nurse practitioners who write a huge share of cash GLP-1, TRT, HRT. Peptide brands chase MDs and miss them.
Required-credibility events (A4M LongevityFest, AMMG, IFM AIC, IHS NY) stay in the mix but should be second in year-one budget priority, not first.
★ SSRP Peptide World Congress is in its own tier — exact-ICP audience, peptide-clinician flagship. The 12 below are ranked by audience × clinical fit × competitor absence × cash-pay density.
| # | Event | When | Where | Attendance | Booth | Why |
|---|---|---|---|---|---|---|
| ★ | SSRP Peptide World Congress | Jun 19-20, 2026 | Las Vegas (TBC) | ~1.5-2.5k peptide clinicians | mid | THE peptide-therapy clinical flagship (Dr. William Seeds); exact-ICP audience, highest peptide-buyer density on calendar — must-attend |
| 1 | AAOMS Annual Meeting | Sep 28 - Oct 3, 2026 | Seattle | ~3-4k OMF surgeons | mid ($8-20k) | Highest dental clinical fit (bone graft + flap healing); broadest dental Rx scope; zero peptide exhibitors |
| 2 | AAP Annual Meeting | Oct 29 - Nov 1, 2026 | Seattle | ~2-3k periodontists | mid ($6-15k) | Published BPC-157 periodontitis animal data; 100% target audience; zero peptide competition |
| 3 | APMA The National | Aug 6-9, 2026 | Nashville | ~2-3k DPMs | mid ($5-12k) | DPMs prescribe in all 50 states; diabetic foot is BPC-157's home turf |
| 4 | Greater NY Dental Meeting | Nov 27 - Dec 1, 2026 | NYC Javits | 50k+ | mid-high ($10-30k) | Largest dental door in US, free entry; broad GP funnel for brand awareness |
| 5 | IOF MAX (orthobiologics) | Jun 17-20, 2026 | Aurora CO | a few hundred | low-mid ($5-15k) | Surgeons already buying PRP/exosomes; peptides are the obvious next SKU; perfect ICP |
| 6 | NAMS (menopause) | Oct 21-24, 2026 | San Diego | ~1,300 | mid ($8-20k) | NP-heavy, cash-pay, peptide vendors absent; PT-141 + kisspeptin + BPC angles |
| 7 | SAWC Spring (wound care) | Apr 8-12, 2026 | Charlotte | ~3k+ | mid | Wound healing is the BPC-157/TB-500 evidence base; peptide brands aren't here |
| 8 | AHVMA (holistic vet) | Oct 3-6, 2026 | San Diego | ~600-900 DVMs | low-mid ($2-6k) | Most receptive vet audience for regenerative; zero peptide competition |
| 9 | Androgen Society | Jun 11-12, 2026 | Chicago | a few hundred TRT MDs | low-mid ($5-12k) | Pure TRT clinician audience; gonadorelin/CJC/kisspeptin fit perfectly |
| 10 | AANP National (NPs) | Jun 23-27, 2026 | Vegas (Venetian) | thousands of NPs | mid-high ($15-30k) | NPs run huge share of cash GLP-1/TRT/HRT; peptide vendors miss them |
| 11 | ASSH (hand surgery) | Sep 17-19, 2026 | Boston | ~3-4k hand surgeons | mid ($6-15k) | Tendon/ligament/nerve regen = classic peptide thesis; broad Rx; zero competition |
| 12 | Concierge Medicine Forum | Fall 2026 (TBC) | Atlanta area | ~300-500 MDs | low-mid | Every attendee a cash-pay MD; small but ICP-pure; segment essentially unworked |
Front-load cheap high-fit underserved events to build booth-ops muscle, then layer in table-stakes credibility shows once a baseline ROI signal exists.
Click a month to filter the catalog below.